// App-Quantinova.ai

2374 : Pharmacologic Thromboprophylaxis Is Frequently Prescribed In Hospitalized Cancer Patients At Academic Medical Centers: A Prospective, Cross-Sectional, Multi-Center Study

Researchers

Presenter

  • Adam A. Rojan

Principal Investigators

  • Nadia Q. Rehman

  • Renee E. Funches

  • Michael B. Streiff

  • Alok A. Khorana

  • Jeffrey I. Zwicker

  • Federico Campigotto

  • Jonathan Webster

  • Gregory C. Connolly

  • Anita Aggarwal

  • Dalia Mobarek

  • Donna S. Neuberg

  • Ted Wun

  • Frederick Rickles

Medical Centers

  • Hematology Section, VA Medical Center and George Washington University, Washington, DC

  • The George Washington University, Washington, DC

  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

  • University of California, Davis School of Medicine, Sacramento, CA

  • Dana-Farber Cancer Institute, Boston, MA

  • Hematology/Oncology, VAMC, Washington, DC

  • Taussig Cancer Institute Cleveland Clinic, Cleveland, OH

  • The Johns Hopkins Medical Institutions, Baltimore, MD

  • Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Boston, MA

  • University of Rochester Medcal Center, Rochester, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Venous thrombosis

  • Thrombocytopenia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved